Logos Global Management »

Q32 Bio shares owned by Logos Global Management

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Logos Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 800k 12.74

More positions owned by Logos Global Management

Erasca (ERAS)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Ideaya Biosciences (IDYA)
Biontech Se Sponsored Ads (BNTX)
Vera Therapeutics Cl A (VERA)
Tango Therapeutics (TNGX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Dyne Therapeutics (DYN)
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Logos Global Management

Top funds holding Q32 Bio

OrbiMed Advisors
Boxer Capital Management
Atlas Venture Life Science Advisors
BVF
RA Capital Management
Point72 Asset Management
Opaleye Management
Logos Global Management
Ikarian Capital
Vanguard Capital Management
Acorn Capital Advisors
Woodline Partners
American Century Companies
Sanofi
Acadian Asset Management

View all funds holding Q32 Bio